US Stock MarketDetailed Quotes

Cyclerion Therapeutics (CYCN)

Watchlist

3.000
-0.020-0.66%

Close May 19 16:00 ET

3.000
0.0000.00%

Post 16:10 ET

12.99MMarket Cap-2.29P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cyclerion Therapeutics (CYCN) Balance Sheet

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2026

(FY)Dec 31, 2025

(Q4)Dec 31, 2025

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

Assets

Current assets

Cash, cash equivalents and short term investments

-22.42%2.82M

0.25%3.24M

59.05%4.57M

-34.48%3.01M

-36.11%3.64M

-57.31%3.23M

-68.47%2.87M

-18.67%4.59M

-Cash and cash equivalents

-22.42%2.82M

0.25%3.24M

59.05%4.57M

-34.48%3.01M

-36.11%3.64M

-57.31%3.23M

-68.47%2.87M

-18.67%4.59M

Receivables

--0

79.86%1M

127.27%100K

--525K

--581K

--556K

--44K

----

-Accounts receivable

--0

79.86%1M

127.27%100K

--525K

--581K

--556K

--44K

----

Prepaid assets

-0.39%255K

-8.79%384K

-37.84%386K

298.28%462K

-16.88%256K

-4.75%421K

-14.46%621K

-88.89%116K

Other current assets

-47.62%11K

-31.25%11K

0.00%11K

145.45%27K

110.00%21K

45.45%16K

-63.33%11K

-97.43%11K

Total current assets

-31.31%3.09M

9.70%4.64M

42.76%5.07M

-14.74%4.02M

-25.22%4.5M

-47.35%4.23M

-64.03%3.55M

-33.71%4.72M

Non current assets

Net PPE

--66K

----

--0

----

-Gross PPE

--66K

----

0.00%126K

----

-Accumulated depreciation

----

0.00%-126K

----

Investments and advances

0.00%5.35M

--5.35M

Total non current assets

1.23%5.42M

0.00%5.35M

79.29%5.35M

Total assets

-13.63%8.51M

4.28%9.99M

17.05%10.42M

-6.91%9.37M

-13.35%9.85M

-28.41%9.58M

-41.51%8.9M

-0.32%10.07M

Liabilities

Current liabilities

Payables

-5.38%457K

30.26%508K

57.89%480K

-29.03%462K

-34.82%483K

-67.45%390K

-62.65%304K

-65.08%651K

-accounts payable

-5.38%457K

30.26%508K

57.89%480K

-29.03%462K

-34.82%483K

-67.45%390K

-62.65%304K

-65.08%651K

Current accrued expenses

110.02%1.13M

25.37%341K

-44.76%195K

-34.89%278K

0.00%539K

-64.90%272K

-66.44%353K

-82.02%427K

Other current liabilities

131.11%104K

26.67%38K

137.21%102K

-70.59%60K

-72.05%45K

-73.45%30K

-72.78%43K

16.57%204K

Current liabilities

60.64%1.71M

24.14%900K

25.29%877K

-37.60%800K

-25.95%1.07M

-65.24%725K

-70.10%700K

-74.09%1.28M

Non current liabilities

Total non current liabilities

--0

Total liabilities

60.64%1.71M

24.14%900K

25.29%877K

-37.60%800K

-25.95%1.07M

-65.24%725K

-70.10%700K

-74.09%1.28M

Shareholders'equity

Share capital

--0

-common stock

--0

-Preferred stock

--0

Retained earnings

-1.96%-274.2M

-1.32%-271.02M

-0.82%-270.22M

-0.73%-269.25M

-1.11%-268.92M

-1.16%-267.49M

-2.02%-268.02M

1.11%-267.3M

Paid-in capital

1.18%280.99M

1.36%280.11M

1.28%279.76M

0.63%277.82M

0.65%277.7M

0.23%276.34M

0.22%276.22M

0.23%276.08M

Gains losses not affecting retained earnings

----

--0

Total stockholders'equity

-22.65%6.79M

2.66%9.09M

16.35%9.54M

-2.43%8.57M

-11.52%8.78M

-21.60%8.85M

-36.32%8.2M

70.54%8.78M

Total equity

-22.65%6.79M

2.66%9.09M

16.35%9.54M

-2.43%8.57M

-11.52%8.78M

-21.60%8.85M

-36.32%8.2M

70.54%8.78M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2026	(FY)Dec 31, 2025	(Q4)Dec 31, 2025	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024
Assets
Current assets
Cash, cash equivalents and short term investments	-22.42%2.82M	0.25%3.24M	0.25%3.24M	59.05%4.57M	-34.48%3.01M	-36.11%3.64M	-57.31%3.23M	-57.31%3.23M	-68.47%2.87M	-18.67%4.59M
-Cash and cash equivalents	-22.42%2.82M	0.25%3.24M	0.25%3.24M	59.05%4.57M	-34.48%3.01M	-36.11%3.64M	-57.31%3.23M	-57.31%3.23M	-68.47%2.87M	-18.67%4.59M
Receivables	--0	79.86%1M	79.86%1M	127.27%100K	--525K	--581K	--556K	--556K	--44K	----
-Accounts receivable	--0	79.86%1M	79.86%1M	127.27%100K	--525K	--581K	--556K	--556K	--44K	----
Prepaid assets	-0.39%255K	-8.79%384K	-8.79%384K	-37.84%386K	298.28%462K	-16.88%256K	-4.75%421K	-4.75%421K	-14.46%621K	-88.89%116K
Other current assets	-47.62%11K	-31.25%11K	-31.25%11K	0.00%11K	145.45%27K	110.00%21K	45.45%16K	45.45%16K	-63.33%11K	-97.43%11K
Total current assets	-31.31%3.09M	9.70%4.64M	9.70%4.64M	42.76%5.07M	-14.74%4.02M	-25.22%4.5M	-47.35%4.23M	-47.35%4.23M	-64.03%3.55M	-33.71%4.72M
Non current assets
Net PPE	--66K	----	----	----	----	----	--0	--0	----	----
-Gross PPE	--66K	----	----	----	----	----	0.00%126K	0.00%126K	----	----
-Accumulated depreciation	----	----	----	----	----	----	0.00%-126K	0.00%-126K	----	----
Investments and advances	0.00%5.35M	0.00%5.35M	0.00%5.35M	0.00%5.35M	0.00%5.35M	0.00%5.35M	0.00%5.35M	0.00%5.35M	0.00%5.35M	--5.35M
Total non current assets	1.23%5.42M	0.00%5.35M	0.00%5.35M	0.00%5.35M	0.00%5.35M	0.00%5.35M	0.00%5.35M	0.00%5.35M	0.00%5.35M	79.29%5.35M
Total assets	-13.63%8.51M	4.28%9.99M	4.28%9.99M	17.05%10.42M	-6.91%9.37M	-13.35%9.85M	-28.41%9.58M	-28.41%9.58M	-41.51%8.9M	-0.32%10.07M
Liabilities
Current liabilities
Payables	-5.38%457K	30.26%508K	30.26%508K	57.89%480K	-29.03%462K	-34.82%483K	-67.45%390K	-67.45%390K	-62.65%304K	-65.08%651K
-accounts payable	-5.38%457K	30.26%508K	30.26%508K	57.89%480K	-29.03%462K	-34.82%483K	-67.45%390K	-67.45%390K	-62.65%304K	-65.08%651K
Current accrued expenses	110.02%1.13M	25.37%341K	25.37%341K	-44.76%195K	-34.89%278K	0.00%539K	-64.90%272K	-64.90%272K	-66.44%353K	-82.02%427K
Other current liabilities	131.11%104K	26.67%38K	26.67%38K	137.21%102K	-70.59%60K	-72.05%45K	-73.45%30K	-73.45%30K	-72.78%43K	16.57%204K
Current liabilities	60.64%1.71M	24.14%900K	24.14%900K	25.29%877K	-37.60%800K	-25.95%1.07M	-65.24%725K	-65.24%725K	-70.10%700K	-74.09%1.28M
Non current liabilities
Total non current liabilities	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Total liabilities	60.64%1.71M	24.14%900K	24.14%900K	25.29%877K	-37.60%800K	-25.95%1.07M	-65.24%725K	-65.24%725K	-70.10%700K	-74.09%1.28M
Shareholders'equity
Share capital	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
-common stock	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
-Preferred stock	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Retained earnings	-1.96%-274.2M	-1.32%-271.02M	-1.32%-271.02M	-0.82%-270.22M	-0.73%-269.25M	-1.11%-268.92M	-1.16%-267.49M	-1.16%-267.49M	-2.02%-268.02M	1.11%-267.3M
Paid-in capital	1.18%280.99M	1.36%280.11M	1.36%280.11M	1.28%279.76M	0.63%277.82M	0.65%277.7M	0.23%276.34M	0.23%276.34M	0.22%276.22M	0.23%276.08M
Gains losses not affecting retained earnings	----	----	----	----	----	----	--0	--0	--0	--0
Total stockholders'equity	-22.65%6.79M	2.66%9.09M	2.66%9.09M	16.35%9.54M	-2.43%8.57M	-11.52%8.78M	-21.60%8.85M	-21.60%8.85M	-36.32%8.2M	70.54%8.78M
Total equity	-22.65%6.79M	2.66%9.09M	2.66%9.09M	16.35%9.54M	-2.43%8.57M	-11.52%8.78M	-21.60%8.85M	-21.60%8.85M	-36.32%8.2M	70.54%8.78M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

No. Symbol 5D % Chg

Middle East conflict spreads to the stock market! How should investors respond?

On May 19, Eastern Time, Trump issued a clear countdown: 'in two or three days—maybe Friday, Saturday, Sunday, or early next week'—the U.S. Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm